Few treatments for Parkinson's disease (PD) restore function for extended periods. In a new study published today in the inaugural issue issue of the Journal of Parkinson's Disease, an international group of researchers report that platelet-derived growth factor-BB (PDGF-BB) restored function in rodents and shows promise as a clinical candidate drug for treatment of PD.
- New animal study shows promise for development of Parkinson's disease drugThu, 9 Jun 2011, 12:10:07 EDT
- Finnish scientists discover nerve growth factor with therapeutic potential in Parkinson's diseaseSat, 29 Aug 2009, 1:35:12 EDT
- A promising target for developing treatments against Parkinson's diseaseMon, 23 Aug 2010, 17:56:43 EDT
- New method for measuring Parkinson's disease prevalence reveals sharp increase in IsraelThu, 9 Jun 2011, 12:09:56 EDT
- Long-term effects of early Parkinson's treatments similarMon, 9 Mar 2009, 18:30:17 EDT